Advertisement
UK markets close in 2 hours 6 minutes
  • FTSE 100

    8,036.15
    +12.28 (+0.15%)
     
  • FTSE 250

    19,700.73
    +101.34 (+0.52%)
     
  • AIM

    752.91
    +3.73 (+0.50%)
     
  • GBP/EUR

    1.1616
    +0.0027 (+0.23%)
     
  • GBP/USD

    1.2391
    +0.0041 (+0.33%)
     
  • Bitcoin GBP

    53,354.52
    +37.62 (+0.07%)
     
  • CMC Crypto 200

    1,421.44
    +6.68 (+0.47%)
     
  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     
  • DOW

    38,239.98
    +253.58 (+0.67%)
     
  • CRUDE OIL

    81.37
    -0.53 (-0.65%)
     
  • GOLD FUTURES

    2,327.00
    -19.40 (-0.83%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     
  • DAX

    18,066.03
    +205.23 (+1.15%)
     
  • CAC 40

    8,085.30
    +44.94 (+0.56%)
     

1 Beaten-Down Stock With 10X Potential

1 Beaten-Down Stock With 10X Potential

The biotech industry is an excellent place to start. Clinical trial victories and regulatory approvals can send shares of a biotech soaring, especially one with a relatively small stock market capitalization. Let's look closer at one biotech whose shares have been hammered over the past few months, Axsome Therapeutics (NASDAQ: AXSM), and consider why this company still has some serious potential.